Associations between carotid atherosclerosis and high factor VIII activity, dyslipidemia, and hypertension

Stroke

Volumn 28, Issue 1, 1997, Pages 88-94

  Pan, Wen Harn ^a,b   Bai, Chyi Huey ^a,b   Chen, Jiunn Rong ^c   Chiu, Hou Chang ^c  

^a INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c SHIN KONG WU HO SU MEMORIAL HOSPITAL   (Taiwan)

Author keywords

carotid artery occlusion; China; coagulation; glucose; hypertension

Indexed keywords

BLOOD CLOTTING FACTOR 8;

ADULT; AGED; ARTICLE; BLOOD CLOTTING; CAROTID ARTERY DISEASE; CHINA; DYSLIPIDEMIA; FEMALE; HUMAN; HYPERTENSION; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; STROKE;

EID: 0031023774     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.28.1.88     Document Type: Article

References (27)

1. Meade TW, Imeson J, Stirling Y. Effects of changes in smoking and other characteristics on clotting factors and the risk of ischaemic heart disease. Lancet. 1987;26:986-988.
2. Meade TW, Mellows S, Brozovic M, Miller GJ, Chakrabarti RR, North WRS, Haines AP, Stirling Y, Imeson JD, Thompson SG. Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study. Lancet 1986;2:533-537.
3. Balleisen L, Schulte H, Assmann G, Epping PH, van de Loo J. Coagulation factors and the progress of coronary heart disease. Lancet. 1987;2:461. Letter.
4. Kannel WB, D'Agostino RB, Belanger AJ. Fibrinogen, cigarette smoking and risk cardiovascular disease: insights from the Framingham study. Am Heart J. 1987;113:1006-1010.
5. Wilhelmsen L, Svarsudd K, Korsan-Bengsten K, Larsson B, Welin L, Tibblin G. Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med. 1984;311:501-505.
6. Meade TW, Cooper JA, Stirling Y, Howarth DJ, Ruddock V, Miller GJ, Factor VIII, ABO blood group and the incidence of ischaemic heart disease. Br J Haematol. 1994;88:601-607.
7. Davies MJ, Thomas A. Thrombosis and acute coronary-artery lesions in sudden cardiac ischemic death. N Engl J Med 1984;310:1137-1140.
8. De Wood MA, Spores J, Notske R, Mouser LT, Burroughs R, Golden MS, Lang HT. Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction. N Engl J Med. 1980; 303:897-902.
9. Jeng J-S, Chung M-Y, Yip P-K, Hwang B-S, Chang Y-C. Extracranial carotid atherosclerosis and vascular risk factors in different types of ischemic stroke in Taiwan. Stroke. 1994;25:1989-1993.
10. Feldmann E, Daneault N, Ho KJ, Pessin MS, Langenberg P, Caplan LR. Chinese-white differences in the distribution of occlusive cerebrovascular disease. Neurology. 1990;40:1541-1545.
11. Sosef MN, Bosch JG, van Oostayen J, Visser T, Reiber JH, Rosendaal FR. Relation of plasma coagulation factor VII and fibrinogen to carotid artery intima-media thickness. Thromb Haemost. 1994;72: 250-254.
12. Kiechl S, Willeit J, Egger G, Oberhollenzer M, Aichner F. Alcohol consumption and carotid atherosclerosis: evidence of dose-dependent atherogenic and antiatherogenic effects. Results from the Bruneck study. Stroke. 1994;25:1593-1598.
13. Salomaa V, Stinson V, Kark JD, Folsom AR, Davis CE, Wu KK. Association of fibrinolytic parameters with early atherosclerosis: the ARJC Study. Atherosclerosis Risk in Communities Study. Circulation. 1995;91:284-290.
14. Tracy RP, Bovill EG, Yanez D, Psaty BM, Fried LP, Heiss G, Lee M, Polak JF, Savage PJ. Fibrinogen and factor VIII, but not factor VII, are associated with measures of subclinical cardiovascular disease in the elderly: results from the Cardiovascular Health Study. Arterioscler Thromb Vasc Biol. 1995;15:1269-1279.
15. Levenson J, Giral P, Razavian M, Gariepy J, Simon A. Fibrinogen and silent atherosclerosis in subjects with cardiovascular risk factors. Arterioscler Thromb Vasc Biol. 1995;15:1263-1268.
16. Wu KK, Aaron RF, Heiss G, Davis CE, Conlan MG, Barnes R, for the ARIC Study Investigators. Association of coagulation factors and inhibitors and carotid artery atherosclerosis: early results of the Atherosclerosis Risk in Communities (ARIC) Study. Ann Epidemiol. 1992;2:471-480.
17. Bots ML, Breslau PJ, Briet E, de Bruym AM, van Vliet HHDM, van den Ouweland F, de Jong PTVM, Hofman A, Grobbee DE. Cardiovascular determinants of carotid artery disease: the Rotterdam elderly study. Hypertension. 1992;19:717-720.
18. Folsom AR, Wu KK, Shahar E, Davis CE, for the Atherosclerosis Risk in Communities (ARIC) Study Investigators. Association of hemostatic variables with prevalent cardiovascular disease and asymptomatic carotid artery atherosclerosis. Arterioscler Thromb. 1993;13: 1829-1836.
19. Yen C-J, Pan W-H, Bai C-H, You M-S, Wang W-C, Wang L-Y, Lee T-K. Curvilinear relations between age and hemostatic parameters in Chinese. Thromb Haemost. 1994;72:239-243.
20. National Cholesterol Education Program. Second report of the expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel II). Circulation. 1994;89:1336-1432.
21. Rosendaal FR, Varekamp I, Smit C, Brocker-Vriends AHJT, van Dijck H, Vandenbroucke JP, Hermans J, Suurmeijer TPBM, Briet E. Mortality and causes of death in Dutch haemophiliacs 1973-1986. Br J Haematol. 1989;71:71-76.
22. Jones DK, Luddington R, Higenbottam TW, Scott J, Cavarocchi N, Reardon D, Calvin J, Wallwork J. Changes in factor VIII proteins after cardiopulmonary bypass in man suggest endothelial damage. Thromb Haemost. 1988;60:199-204.
23. Brwon Z, Neild GH, Willoughby JJ, Somia NV, Cameron SJ. Increased factor VIII as an index of vascular injury in cyclosporine nephrotoxicity. Transplantation. 1986;42:150-153.
24. Kahaleh MB, Osborn I, LeRoy EC. Increased factor VIII/von Willebrand factor antigen and von Willebrand factor activity in scleroderma and in Raynaud's phenomenon. Ann Intern Med. 1981;94: 482-484.
25. Kingsbury KJ. Relation of ABO blood-groups to atherosclerosis. Lancet. 1971;1:199-203.
26. Medalie JH, Levene C, Papier C, Goldbourt U, Dreyfuss F, Oron D, Neufeld H, Riss E. Blood groups, myocardial infarction and angina pectoris among 10,000 adult males. N Engl J Med. 1981;285:1348-1353.
27. Thompson SG, Kienast J, Pyke SDM, van de Loo JCW, for the European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. N Engl J Med. 1995;332:635-641.